Screener
Protagonist Therapeutics PTGX Business Segments — Income Tax Expense Benefit
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Protagonist Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Employee wages and benefits - discovery (2) | (2,668) | (2,188) | (5,816) | (4,515) |
| Employee wages and benefits - development (2) | (4,949) | (4,658) | (10,901) | (10,142) |
| Employee wages and benefits - general and administrative | (4,357) | (3,483) | (9,080) | (7,315) |
| Stock-based compensation expense | (14,037) | (10,912) | (28,556) | (24,714) |
| Other segment items (3) | (81) | 36 | (28) | 118 |
| Interest income | 6,429 | 7,406 | 12,305 | 14,979 |
| Income tax expense | (2,265) | (172) | (763) | (172) |
| Consolidated net income (loss) | $162,849 | $(34,771) | $166,632 | $(46,426) |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Protagonist Therapeutics's business segments — income tax expense benefit?
- Protagonist Therapeutics (PTGX) reported business segments — income tax expense benefit of $2.27M in Q2 2026.
- How has Protagonist Therapeutics's business segments — income tax expense benefit changed year-over-year?
- Protagonist Therapeutics's business segments — income tax expense benefit increased by 1216.9% year-over-year, from $172K to $2.27M.
- What does business segments — income tax expense benefit mean?
- This metric represents the total income tax expense or benefit recognized by the business segment during the reporting period. It reflects the tax implications of the segment's operational profitability and regulatory environment, providing insight into the net tax impact on the segment's financial performance. Investors use this to understand the effective tax burden associated with the segment's specific activities and jurisdictional operations.
Ask your AI about Protagonist Therapeutics's business segments — income tax expense benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude